Alpha Teknova (NASDAQ:TKNO – Get Free Report) was downgraded by investment analysts at Roth Capital from a “strong-buy” rating to a “hold” rating in a report released on Friday, Zacks reports.
Several other research firms have also weighed in on TKNO. Jefferies Financial Group began coverage on shares of Alpha Teknova in a research note on Thursday, September 17th. They set a “buy” rating and a $9.00 target price for the company. Wall Street Zen raised Alpha Teknova from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. BTIG Research raised Alpha Teknova from a “neutral” rating to a “buy” rating and set a $8.00 price target on the stock in a research report on Tuesday, August 11th. Zacks Research upgraded Alpha Teknova to a “hold” rating in a research report on Thursday, August 6th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Alpha Teknova in a research report on Wednesday, November 4th. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $8.75.
Read Our Latest Stock Analysis on Alpha Teknova
Alpha Teknova Stock Down 2.3%
Alpha Teknova (NASDAQ:TKNO – Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.01. The business had revenue of $12.70 million for the quarter, compared to the consensus estimate of $11.71 million. Alpha Teknova had a negative net margin of 34.76% and a negative return on equity of 24.95%. Analysts predict that Alpha Teknova will post -0.27 EPS for the current fiscal year.
Institutional Trading of Alpha Teknova
Several institutional investors have recently modified their holdings of the company. American Century Companies Inc. acquired a new position in shares of Alpha Teknova in the 3rd quarter valued at $362,000. Marshall Wace LLP bought a new stake in Alpha Teknova in the 3rd quarter valued at $330,000. Empowered Funds LLC bought a new stake in shares of Alpha Teknova during the 3rd quarter valued at $656,000. Susquehanna International Group LLP bought a new stake in Alpha Teknova during the second quarter worth about $115,000. Finally, Bank of America Corp DE bought a new position in Alpha Teknova in the 2nd quarter valued at about $1,453,000. Institutional investors and hedge funds own 13.81% of the company’s stock.
Alpha Teknova Company Profile
Alpha Teknova, Inc. develops and manufactures reagents used in life science research and the development and production of biopharmaceuticals and diagnostic products. Its offerings include cell culture media, buffers, molecular biology reagents, proteins and other laboratory materials. The company provides both catalog products and custom reagent development and manufacturing services. Its customers include biotechnology and pharmaceutical companies, diagnostic developers, academic institutions and research laboratories.
Further Reading
- Five stocks we like better than Alpha Teknova
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.
